Paul Mahon

2018

In 2018, Paul Mahon earned a total compensation of $5.3M as Executive Vice President and General Counsel at United Therapeutics, a 59% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$799,500
Option Awards$3,656,242
Salary$820,000
Other$21,800
Total$5,297,542

Mahon received $3.7M in option awards, accounting for 69% of the total pay in 2018.

Mahon also received $799.5K in non-equity incentive plan, $820K in salary and $21.8K in other compensation.

Rankings

In 2018, Paul Mahon's compensation ranked 1,867th out of 14,244 executives tracked by ExecPay. In other words, Mahon earned more than 86.9% of executives.

ClassificationRankingPercentile
All
1,867
out of 14,244
87th
Division
Manufacturing
668
out of 5,759
88th
Major group
Chemicals And Allied Products
217
out of 2,122
90th
Industry group
Drugs
170
out of 1,811
91st
Industry
Pharmaceutical Preparations
128
out of 1,385
91st
Source: SEC filing on April 29, 2019.

Mahon's colleagues

We found three more compensation records of executives who worked with Paul Mahon at United Therapeutics in 2018.

2018

Martine Rothblatt

United Therapeutics

Chief Executive Officer

2018

Michael Benkowitz

United Therapeutics

Chief Operating Officer

2018

James Edgemond

United Therapeutics

Chief Financial Officer

News

In-depth

You may also like